Cite
HARVARD Citation
Fasching, P. et al. (n.d.). 168PValidation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC). Annals of oncology. p. . [Online].